-
1 Comment
Tonghua Dongbao Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 8.2% below its 200 day moving average.
From a valuation standpoint, the stock is 10.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.6.
Tonghua Dongbao Pharmaceutical Co., Ltd's total revenue sank by 1.3% to $711M since the same quarter in the previous year.
Its net income has increased by 74.1% to $214M since the same quarter in the previous year.
Finally, its free cash flow grew by 65.8% to $250M since the same quarter in the previous year.
Based on the above factors, Tonghua Dongbao Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHG |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE000000H87 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 15B |
|---|---|
| PE Ratio | 41.78 |
| Target Price | 11.04 |
| Beta | 0.24 |
| Dividend Yield | None |
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices. The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. In addition, it offers chemical drugs, such as repaglinide and empagliflozin tablets. Further, the company offers building materials, including plastic steel windows and profiles; and engages in the real estate industry. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 600867.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
